Clinical trials: Intestinal Transplantation
Hypertension
Effect of Gut Microbiome Restoration on Primary Hypertension Via FMT
Mounting preclinical and clinical evidences have proved the causal role of gut microbiota on the pathogenesis of primary hypertension.
- Trial name
- FMT (NCT04406129)
- Testing
- FMT capsules
- Where
- 7 sites in China
- Volunteers
- 120 people
- Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
Liver Metastases, Colorectal Cancer
Liver Transplantation Compared to Chemotherapy in Patients With ColoRectal Cancer
The trial is a randomized control trial. Patients are randomized between Ltx and other treatment that may include further chemotherapy, TACE, SIRT or other available treatment options.
- Trial name
- SECAIII (NCT03494946)
- Testing
- Liver transplantation, Chemotherapy
- Where
- Norway
- Volunteers
- 30 people
- Sponsor
- Oslo University Hospital
Irritable Bowel Syndrome
Faecal Microbiota Transplantation in Irritable Bowel Syndrome
The purpose of thus study is to determine if faecal microbiota transplantation will result in improvement in clinical outcomes in patients with irritable bowel syndrome.
- Trial name
- NCT02423421
- Testing
- Faecal microbiota transplantation
- Where
- Ireland
- Volunteers
- 50 people
- Sponsor
- University College Cork
Epilepsy
Fecal Microbiota Transplantation for Epilepsy
Increasing evidences showed the microbiota effects on neuropsychiatric disorders. This clinical trial aims to evaluate the efficacy and safety of fecal microbiota transplantation for epilepsy.
- Trial name
- NCT02889627
- Testing
- Fecal microbiota suspension
- Where
- China
- Volunteers
- 50 people
- Sponsor
- The Second Hospital of Nanjing Medical University
Inflammatory Bowel Diseases (IBD), Crohn's Disease (CD)
Fecal Microbiota Transplantation in Pediatric Patients
A disturbance in the diversity of gut bacterial composition could be linked to several immune mediated diseases including inflammatory bowel diseases (IBD).
- Conditions
- Inflammatory Bowel Diseases (IBD), Crohn's Disease (CD), Ulcerative Colitis (UC)
- Trial name
- FMT (NCT02108821)
- Testing
- Fecal Microbiota Transplantation (FMT)
- Where
- United States
- Volunteers
- 23 people, healthy volunteers welcome
- Sponsor
- Children's Mercy Hospital Kansas City
Fecal Incontinence
Fecal Microbial Transplantation for the Treatment of Fecal Incontinence in Women
Open label pilot study assessing FMT to treat fecal incontinence in women 50 years of age and older.
- Trial name
- FMT for FI (NCT04201821)
- Testing
- fecal microbial transplantation (FMT)
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- University of Pennsylvania
Clostridium Difficile
Mucosal Versus Fecal Microbiota in FMT
Clostridium difficile infection is the most common cause of antibiotic-associated diarrhea. Treatment of this infection usually occurs using other antibiotics, but many individuals have persistent diarrhea and multiple relapses.
- Trial name
- NCT02133651
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Emory University
Parkinson's Disease
Characterization of Fecal Microbiome Changes After Administration of PRIM-DJ2727 in Parkinson's Disease Patients
The purpose of this study is to characterize the intestinal flora in subjects with Parkinson's Disease (PD) and to determine safety and trends in improvements in diversity of colonic microbiome following fecal microbiota…
- Trial name
- NCT03026231
- Testing
- PRIM-DJ2727
- Sponsor
- The University of Texas Health Science Center, Houston
Ulcerative Colitis
A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative Colitis on Advanced Therapies
Ulcerative colitis (UC) is a chronic inflammatory disease of the colon characterized by superficial mucosal inflammation. Treatment aims to achieve and maintain remission, improve quality of life, and minimize complications.
- Trial name
- BOOST-UC (NCT06906445)
- Testing
- Fecal Microbial Transplantation, Anti-Inflammatory Diet, Advanced Therapy
- Where
- 6 sites in India
- Volunteers
- 220 people
- Sponsor
- All India Institute of Medical Sciences
Acute Leukemia
Effect of Rifaximin on Gut Bacterial Flora Post Stem Cell Transplant in Patients With Acute Leukemia
Goal: This study is a randomized phase II interventional study. The purpose of this study is to see if addition of oral rifaximin tablets during allogeneic stem cell transplant can improve the quality of gut microbiome and reduce…
- Trial name
- NCT06058572
- Testing
- Rifaximin 200Mg Tab, allogenic hematopoietic stem cell transplantation
- Where
- India
- Volunteers
- 166 people
- Sponsor
- Tata Memorial Centre
Inflammatory Bowel Diseases
The Fecal Microbiota Transplantation Registry
The human intestinal microbiota is composed of complex community of 10*13 to 10*14 commensal microorganisms[1]. Human intestine provides a nutrient-rich habitat for intestinal microorganism which allows a diverse ecosystem to…
- Trial name
- NCT03787771
- Where
- Hong Kong
- Volunteers
- 3,000 people
- Sponsor
- Chinese University of Hong Kong
Autism Spectrum Disorder (ASD), Gastro-Intestinal Disorder
The Gut-Brain Study
The purpose of this study is to find out if transplant of fecal matter (stool), also known as fecal microbiota transplantation (FMT), from a healthy person into the intestines of children and young adults with Autism Spectrum…
- Trial name
- NCT03426826
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Children's Hospital Los Angeles
Crohn Disease
Fecal Microbial Transplantation in Patients With Crohn's Disease
Fecal Microbiota Transplantation will be offered to eligible Crohn's disease patient as Investigational New Drug treatment
- Trial name
- NCT03267238
- Testing
- Fecal Microbial Transplantation
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- Stony Brook University
Ulcerative Colitis
Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis
The investigators will test the hypothesis that giving antibiotics prior to fecal transplant therapy for active UC increases the proportion of patients in remission at the end of treatment.
- Trial name
- FMT (NCT02606032)
- Testing
- Metronidazole, Doxycycline, Terbinafine
- Where
- Canada
- Volunteers
- 75 people
- Sponsor
- Hamilton Health Sciences Corporation
Irritable Bowel Syndrome
Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome Without Constipation
Irritable bowel syndrome (IBS) is a complex multifactorial functional disorder, whose pathophysiology is largely associated to an impairment of the intestinal microbiota composition, namely dysbiosis.
- Trial name
- TRAMIR (NCT05803980)
- Testing
- Fecal microbiota transplantation (FMT)
- Where
- Italy
- Volunteers
- 35 people
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Liver Metastasis Colon Cancer
LT for Unresectable Colorectal Liver Metastasis
Unlike hepatocellular carcinoma, liver transplantation in patients with liver metastasis from colorectal cancer is limited in only few centers.
- Trial name
- NCT04874259
- Testing
- Living donor liver transplantation
- Where
- South Korea
- Volunteers
- 20 people
- Sponsor
- Seoul National University Hospital
Crohn's Disease, Inflammatory Bowel Diseases
Autologous Unselected Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease
This study evaluates the safety and clinical benefits of a therapeutic approach using the cyclophosphamide (Cy) + thymoglobulin® (ATG) + granulocyte colony-stimulating factor (G-CSF) conditioning regimen followed by autologous…
- Conditions
- Crohn's Disease, Inflammatory Bowel Diseases, Gastroenteritis
- Trial name
- AutoChron (NCT03000296)
- Testing
- Autologous Hematopoietic Stem Cell Transplantation
- Where
- Brazil
- Volunteers
- 50 people
- Sponsor
- Beneficência Portuguesa de São Paulo
Disorder Related to Renal Transplantation
Polyclonal Antilymphocyte Globulin (ATG) & Intestinal Immune Barrier After Kidney Transplantation
The prevention of allograft rejection in kidney transplantation requires administering to the patient an immunosuppressive regimen of induction.
- Trial name
- GABII (NCT02843841)
- Testing
- Blood and fecal sample.
- Where
- France
- Volunteers
- 63 people
- Sponsor
- Centre Hospitalier Universitaire de Besancon
Healthy, Chronic Kidney Diseases
Innovative Approach to Fecal Microbiota Transplantation (FMT) Applied for Chronic Kidney Disease (CKD)
The aim of this PhD project focuses on the relationship between intestinal microbiota and health in the background of Chronic Kidney Disease (CKD).
- Trial name
- NCT04222153
- Where
- Italy
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
IBD - Inflammatory Bowel Disease
Renal and Urinary Manifestations of Chronic Inflammatory Bowel Diseases.
The association between IBD and kidney diseases is more common than previously thought. However, the data is limited and comes from studies with small sample sizes.
- Trial name
- NCT06814392
- Where
- Italy
- Volunteers
- 1,600 people
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna